Well if you are considering it you might have to wait a year or two for clinical trial results and commercial approval. Most likely it will result in a partnership deal with an established player like Edwards.
But from a technical point of view, it ticks an awful lot of boxes. If the trial results bear this out it's probably going to be irresistible to someone.
Well if you are considering it you might have to wait a year or...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.50 |
Change
-0.550(2.61%) |
Mkt cap ! $393.8M | |||
| Open | High | Low | Value | Volume |
| $21.05 | $21.05 | $20.00 | $268.0K | 13.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 492 | $20.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.50 | 1046 | 2 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
| AVR (ASX) Chart |